Dr Reddy'S Lab Shs Sponsored American Deposit Receipt Repr 1 Sh $44.75

down 0.00


31/7/2014 04:03 PM  |  NYSE : RDY  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get RDY Trend Analysis - it has outperformed the S&P 500 by 6%

Partner Headlines

  1. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  2. Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  3. Earnings Scheduled For May 13, 2014

    Benzinga
  4. India Stocks Rally On Hopes For Pro-Business Government

    IBD
  5. Stocks Rise In Weak Trade, McKesson Up After Hours

    IBD
  6. India Stocks Rally On Hopes For Pro-Business Gov't

    IBD
  7. US Stock Futures Surge Ahead Of Beige Book, Bank of America Earnings

    Benzinga
  8. Should You Buy Actavis?

    GuruFocus
  9. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  10. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  11. Earnings Scheduled For February 11, 2014

    Benzinga
  12. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  13. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  14. US Stock Futures Edge Down Ahead Of Consumer Price Index

    Benzinga
  15. Dr. Reddy's Announces Azacitidine for Injection Approved by FDA

    Benzinga
  16. Dr. Reddy's Launches Donepezil Hydrochloride Tablets, 23 mg

    Benzinga
  17. UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Dr. Reddy's Laboratories ...

    Benzinga
  18. UPDATE: Bank of America Downgrades Dr. Reddy's Laboratories to Neutral ...

    Benzinga
  19. Earnings Scheduled For February 14, 2013

    Benzinga
  20. Dr. Reddy's Announces Offer for OctoPlus is Unconditional

    Benzinga
  21. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  22. A Peek Into The Market Before The Trading Starts

    Benzinga
  23. Dr. Reddy's Launches Desloratadine ODT

    Benzinga
  24. A Peek Into The Market Before The Trading Starts

    Benzinga
  25. Dr. Reddy's Launches Finasteride Tablets

    Benzinga
  26. The 3 Most-Recommended Healthcare Stocks

    GuruFocus
  27. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  28. Foreign Drugmakers Holding Up, But Some Have Flaws

    IBD
  29. A Peek Into The Market Before The Trading Starts

    Benzinga
  30. Dr. Reddy's Launches Cash Offer for OctoPlus for EUR 0.52/Share

    Benzinga
  31. A Peek Into The Market Before The Trading Starts

    Benzinga
  32. Dr. Reddy's Announces Saumen Chakraborty as New CFO

    Benzinga
  33. A Peek Into The Market Before The Trading Starts

    Benzinga
  34. Dr. Reddy's Launches Sildenafil Tablets

    Benzinga
  35. A Peek Into The Market Before The Trading Starts

    Benzinga
  36. Dr. Reddy's Announces Intent to Make Offer for OctoPlus N.V.

    Benzinga
  37. Dr. Reddy's Announces Launch of Montelukast Sodium Oral Granules

    Benzinga
  38. Generic Drugs: Watson Up, Impax Awaits FDA Decision

    IBD
  39. Health Care Sector Wrap

    FoxBusiness
  40. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  41. Financial Breakfast: Morning News Summary for June 6, 2012

    Benzinga
  42. A Peek Into The Market Before The Trading Starts

    Benzinga
  43. From Earlier: Dr. Reddy's Announces the Launch of Over-the-Counter Lansoprazole ...

    Benzinga
  44. Dr. Reddy's Revenues Cross $2 Billion Milestone* in FY12

    Benzinga
  45. Dr. Reddy Labs

    IBD
  46. Dr. Reddy's Clarifies Media Reports

    Benzinga
  47. 5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth: RDY, ...

    GuruFocus
Trading Center